Abstract:Nutritional strategy employed during pregnancy has a significant impact on pregnancy progression and outcome. However, there is paucity of evidence on the effect of omega (n)‐3 polyunsaturated fatty acids (PUFA) intake on maternal metabolic regulation and fetal outcome at different stages of pregnancy. We investigated the effects of diets varying in both the quantity and the quality of fat on maternal metabolic profile during pregnancy and its effect on the fetal number of C57BL/6 mice. Female mice (8 weeks) were fed diets varying in the quantity of fat (5% vs. 11%) for one week prior to mating and throughout pregnancy. The 5% diet contained fish oil as a source of n‐3 PUFA, while the 11% diet contained soybean oil. The females were checked for vaginal plug to confirm pregnancy. Maternal blood and livers were collected at early‐ (day 6.5), mid‐ (day 12.5) and late‐pregnancy (day 18.5). Lipids were extracted from red blood cells (RBC) and liver, and fatty acid composition was determined using gas chromatography. Plasma and liver triacylglycerol (TG) and total cholesterol (TC) were measured using kits. Hepatic mRNA expression of lipogenic enzymes (acetyl‐CoA carboxylase; ACC1 and fatty acid synthase; FAS) was measured using qPCR. Macrophage cholesterol efflux assay was performed using J774 cells treated with 2% maternal plasma. Plasma progesterone and estradiol were determined using Architect System. Fetal weight, implantation sites and the number of fetuses sustained throughout pregnancy were recorded. Two way analysis of variance was used to determine the main effects of diet and time, and Bonferrroni pairwise comparison was used to determine statistical difference when an interaction was observed; P<0.05 was considered significant. The 5% diet group had higher amount of RBC alpha‐linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) at each stage of pregnancy, compared to the 11% group (P<0.0001). Interestingly, ALA was not detected at day 12.5 and 18.5 in the 11% group. The 5% group showed higher plasma TG (P<0.001) and lower TC (P<0.05), compared to the 11% group at mid and late pregnancy. Hepatic TC levels were higher in the 5% group, compared to the 11% group (P<0.05) at mid and late pregnancy. The plasma from the 5% group at mid and late pregnancy increased cholesterol efflux, compared to the 11% group (P<0.005). The mRNA expression of ACC1 and FAS were higher in the 5% group, compared to the 11% group (P<0.05) at mid and late pregnancy. Diet had an independent effect on maternal sex‐hormones, revealing significantly higher levels of progesterone and estradiol in the 5% group (P<0.005), compared to the 11% group. The number of fetuses sustained till day 18.5 was higher in the 5% group (average of 8 fetuses), compared to the 11% group (average of 5.1 fetuses) (P<0.05). In conclusion, a low fat diet causes an increase in de‐novo lipid synthesis, likely to meet the needs of the developing fetus. The 11% group showed rapid conversion of ALA to DHA at mid and late gestation. Higher levels of progesterone and estradiol in the 5% group may be responsible for sustaining a higher fetal number. Our findings highlight the importance of the quantity and the quality of fat during pregnancy on fetal outcome. Support or Funding Information Funded by Natural Sciences and Engineering Research Council of Canada (NSERC)

Maternal dietary deficiency of n-3 fatty acids affects metabolic and epigenetic phenotypes of the developing fetus

Placental Epigenome Impacts Fetal Development: Effects of Maternal Nutrients and Gut Microbiota

Dietary omega-3 fatty acid deficiency from pre-pregnancy to lactation affects expression of genes involved in hippocampal neurogenesis of the offspring

Linoleic and Arachidonic Fatty Acids and their Potential Relationship with Inflammation, Pregnancy, and Fetal Development

Maternal omega-3 fatty acid deficiency affects fetal thermogenic development and postnatal musculoskeletal growth in mice

Maternal diet high in Omega-3 fatty acids upregulate genes involved in neurotrophin signalling in fetal brain during pregnancy in C57BL/6 mice

Maternal Obesity and Gut Microbiota Are Associated with Fetal Brain Development

Role of omega‐6 and omega‐3 fatty acids in fetal programming

Perinatal Dietary Polyunsaturated Fatty Acids in Brain Development, Role in Neurodevelopmental Disorders

Impact of Maternal Obesity on the Metabolism and Bioavailability of Polyunsaturated Fatty Acids during Pregnancy and Breastfeeding

Maternal Omega-3 Nutrition, Placental Transfer and Fetal Brain Development in Gestational Diabetes and Preeclampsia

Maternal exposure to an n-3 polyunsaturated fatty acid diet decreases mammary cancer risk of female offspring in adulthood.

A Maternal Diet Enriched with Longer Chain Omega‐ 3 Polyunsaturated Fatty Acids Increased Lipogenesis and Fetal Outcome in C57bl/6 Mice

The Maternal Omega-3 Long-Chain Polyunsaturated Fatty Acid Concentration in Early Pregnancy and Infant Neurodevelopment: The ECLIPSES Study

Association Between Maternal Erythrocyte PUFAs During Pregnancy and Neurodevelopment in Children at 2 Years of Age: a Birth Cohort Study

Maternal Diet of Polyunsaturated Fatty Acid Altered the Cell Proliferation in the Dentate Gyrus of Hippocampus and Influenced Glutamatergic and Serotoninergic Systems of Neonatal Female Rats

Associations between maternal fish intake, maternal and cord polyunsaturated fatty acid concentrations and offspring anthropometrics at birth and at 7 and 13 years of age

Maternal N-3 Fatty Acid Supplementation Has an Immediate Impact on the Human Milk Fatty Acid Composition.

Effect of a High Linoleic Acid Diet on Pregnant Women and Their Offspring

Maternal supplementation with n-3 fatty acids affects placental lipid metabolism, inflammation, oxidative stress, the endocannabinoid system, and the neonate cytokine concentrations in dairy cows

Effect of dietary intervention to reduce the n-6/n-3 fatty acid ratio on maternal and fetal fatty acid profile and its relation to offspring growth and body composition at 1 year of age